Aaron Lukas, Ph.D., joined the firm’s Intellectual Property group in 2012 as an Associate in the Washington, D.C. office. Dr. Lukas concentrates his practice in complex patent cases for clients in the pharmaceutical, biotechnology, and semiconductor industries.
Dr. Lukas is a registered patent attorney and focuses his practice on the representation of generic pharmaceutical companies in Hatch-Waxman litigation. His practice also includes representing clients preparing patentability, infringement, and invalidity opinions, as well as preparing and prosecuting U.S. and foreign patent applications. Dr. Lukas has provided opinions and drafted and prosecuted patent applications in a wide range of high technology fields including pharmaceuticals, therapeutic methods, nanotechnology, gene synthesis, recombinant DNA technology, diagnostic assays, and semiconductor devices.
Dr. Lukas has research experience in organic chemistry, nanotechnology, and semiconductors. Prior to attending law school, Dr. Lukas was a Senior Research Scientist at Air Products and Chemicals, Inc., where he researched next generation thin film precursors and deposition methods for use in flat panel displays, interconnects, and other high tech applications (2001-2005). That research has resulted in more than 10 issued patents. Dr. Lukas's research experience also includes work as a Graduate Research Assistant at Northwestern University's International Center for Nanotechnology and Department of Chemistry, where as a part of his doctoral research he synthesized and studied visible light-absorbing organic molecules for use as molecular switching devices (1996-2001). He is also a graduate of Georgetown Law, and earned bachelor's degrees in Chemistry and Humanities, cum laude, from Seattle University.